The economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal

详细信息    查看全文

• 作者：Luís Filipe Azevedo ; Altamiro Costa-Pereira…
• 关键词：Chronic pain ; Costs ; Productivity ; Cost of illness ; Economic impact ; I10 ; I14 ; I18
• 刊名：The European Journal of Health Economics
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：17
• 期：1
• 页码：87-98
• 全文大小：704 KB
• 参考文献：1.Maniadakis, N., Gray, A.: The economic burden of back pain in the UK. Pain 84(1), 95–103 (2000)PubMed CrossRef
  2.Thomsen, A.B., Sorensen, J., Sjogren, P., Eriksen, J.: Chronic non-malignant pain patients and health economic consequences. Eur J Pain 6(5), 341–352 (2002)PubMed CrossRef
  3.Turk, D.C.: Chronic non-malignant pain patients and health economic consequences. Eur J Pain 6(5), 353–355 (2002). doi:10.​1016/​S1090-3801(02)00024-1 PubMed CrossRef
  4.Goldberg, D.S., McGee, S.J.: Pain as a global public health priority. BMC Public Health 11, 770 (2011). doi:10.​1186/​1471-2458-11-770 PubMed PubMedCentral CrossRef
  5.Breivik, H.: A major challenge for a generous welfare system: a heavy socio-economic burden of chronic pain conditions in Sweden–and how to meet this challenge. Eur J Pain 16(2), 167–169 (2012). doi:10.​1002/​j.​1532-2149.​2011.​00025.​x PubMed CrossRef
  6.Juniper, M., Le, T.K., Mladsi, D.: The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opin Pharmacother 10(16), 2581–2592 (2009). doi:10.​1517/​1465656090330406​3 PubMed CrossRef
  7.Leadley, R.M., Armstrong, N., Lee, Y.C., Allen, A., Kleijnen, J.: Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain. J Pain Palliat care Pharmacother 26(4), 310–325 (2012). doi:10.​3109/​15360288.​2012.​736933 PubMed CrossRef
  8.Maetzel, A., Li, L.: The economic burden of low back pain: a review of studies published between 1996 and 2001. Best Pract Res Clin Rheumatol 16(1), 23–30 (2002). doi:10.​1053/​berh.​2001.​0204 PubMed CrossRef
  9.Nachemson, A.: Chronic pain–the end of the welfare state? Qual Life Res 3(Suppl 1), S11–S17 (1994)PubMed CrossRef
  10.Phillips, C.J.: Economic burden of chronic pain. Expert Rev Pharmacoecon Outcomes Res 6(5), 591–601 (2006). doi:10.​1586/​14737167.​6.​5.​591 PubMed CrossRef
  11.Fit for work Europe website: fit for work? Musculoskeletal disorders in the European workforce. Accessed from www.​fitforworkeurope​.​eu last accessed in June 2013. (2009)
  12.Engel, C.C., von Korff, M., Katon, W.J.: Back pain in primary care: predictors of high health-care costs. Pain 65(2–3), 197–204 (1996)PubMed CrossRef
  13.Mehra, M., Hill, K., Nicholl, D., Schadrack, J.: The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis. J Med Econ 15(2), 245–252 (2012). doi:10.​3111/​13696998.​2011.​642090 PubMed CrossRef
  14.van Tulder, M.W., Koes, B.W., Bouter, L.M.: A cost-of-illness study of back pain in The Netherlands. Pain 62(2), 233–240 (1995)PubMed CrossRef
  15.Depont, F., Hunsche, E., Abouelfath, A., Diatta, T., Addra, I., Grelaud, A., Lagnaoui, R., Molimard, M., Moore, N.: Medical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in France. Fundam Clin Pharmacol 24(1), 101–108 (2010). doi:10.​1111/​j.​1472-8206.​2009.​00730.​x PubMed CrossRef
  16.Gannon, B., Finn, D.P., O’Gorman, D., Ruane, N., McGuire, B.E.: The cost of chronic pain: an analysis of a regional pain management service in Ireland. Pain Med (2013). doi:10.​1111/​pme.​12202 PubMed
  17.Garattini, L., Koleva, D., Motterlini, N., Cornago, D.: Medical costs of chronic musculoskeletal pain in Italy. Clin Drug Investig 27(2), 139–148 (2007)PubMed CrossRef
  18.Guerriere, D.N., Choiniere, M., Dion, D., Peng, P., Stafford-Coyte, E., Zagorski, B., Banner, R., Barton, P.M., Boulanger, A., Clark, A.J., Gordon, A.S., Guertin, M.C., Intrater, H.M., Lefort, S.M., Lynch, M.E., Moulin, D.E., Ong-Lam, M., Racine, M., Rashiq, S., Shir, Y., Taenzer, P., Ware, M.: The Canadian STOP-PAIN project—Part 2: what is the cost of pain for patients on waitlists of multidisciplinary pain treatment facilities? Can J Anaesth 57(6), 549–558 (2010). doi:10.​1007/​s12630-010-9306-4 PubMed CrossRef
  19.Kronborg, C., Handberg, G., Axelsen, F.: Health care costs, work productivity and activity impairment in non-malignant chronic pain patients. Eur J Health Econ 10(1), 5–13 (2009). doi:10.​1007/​s10198-008-0096-3 PubMed CrossRef
  20.Hutubessy, R.C., van Tulder, M.W., Vondeling, H., Bouter, L.M.: Indirect costs of back pain in the Netherlands: a comparison of the human capital method with the friction cost method. Pain 80(1–2), 201–207 (1999)PubMed CrossRef
  21.Gouveia, M., Augusto, M.: Custos indirectos da dor crónica em Portugal (Indirect costs of chronic pain). Rev Port Saúde Pública 2(29), 100–107 (2011)CrossRef
  22.Raftery, M.N., Ryan, P., Normand, C., Murphy, A.W., de la Harpe, D., McGuire, B.E.: The economic cost of chronic noncancer pain in Ireland: results from the PRIME study, part 2. J Pain 13(2), 139–145 (2012). doi:10.​1016/​j.​jpain.​2011.​10.​004 PubMed CrossRef
  23.Gustavsson, A., Bjorkman, J., Ljungcrantz, C., Rhodin, A., Rivano-Fischer, M., Sjolund, K.F., Mannheimer, C.: Socio-economic burden of patients with a diagnosis related to chronic pain–register data of 840,000 Swedish patients. Eur J Pain 16(2), 289–299 (2012). doi:10.​1016/​j.​ejpain.​2011.​07.​006 PubMed CrossRef
  24.Azevedo, L.F., Costa-Pereira, A., Mendonça, L., Dias, CC., Castro-Lopes, J.M.: Epidemiology of chronic pain: a population-based nationwide study on its prevalence, characteristics and associated disability in Portugal. J. Pain. 13(8):773–783 (2012).  doi:10.​1016/​j.​jpain.​2012.​05.​012 PubMed CrossRef
  25.Azevedo, L.F., Costa-Pereira, A., Mendonça, L., Dias, CC., Castro-Lopes, J.M.: Chronic pain and health services utilization: is there overuse of diagnostic tests and inequalities in nonpharmacologic treatment methods utilization? Med. Care. 51(10):859–869 (2013). doi:10.​1097/​MLR.​0b013e3182a53e4e​ PubMed CrossRef
  26.IASP: subcommittee on taxonomy. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Pain. p 226 (1986)
  27.Drummond, M.F., Sculpher, M.J., Torrance, G.W., O’Brien, B.J., Stoddart, G.L.: Methods for the economic evaluation of health care programmes, 3rd edn. Oxford University Press, New York (2005)
  28.Administração Central do Sistema de Saúde (ACSS): Base de Dados dos Elementos Analíticos (BDEA) do Sistema Nacional de Saúde. Accessed from http://​www.​acss.​min-saude.​pt/​Publicações/​SNS/​InformaçãodeGest​ão/​tabid/​124/​language/​pt-PT/​Default.​aspx [last accessed in June 2013] (2010). Accessed June 2010
  29.Ministério da Saúde [Portuguese Health Ministery]: DR série, Portaria no 132/2009 de 30 de Janeiro—Regulamento das tabelas de preços das instituições do SNS. Accessed from http://​www.​portaldasaude.​pt/​NR/​rdonlyres/​7A929657-9E9D-4FCC-85E1-A5DC40E64414/​0/​Portaria132_​2009Regulamentop​re%C3%A7osSNS.​pdf [last accessed in June 2013]. (2009)
  30.INFARMED: Infomed—Base de dados de medicamentos [Infomed—National Medicines Database]. Accessed from http://​www.​infarmed.​pt/​infomed/​inicio.​php [last accessed in June 2013] (2010). Accessed June 2010
  31.The World Bank—PPP conversion factors. http://​data.​worldbank.​org/​indicator/​PA.​NUS.​PPP . Accessed Oct 2014
  32.INE: Quadro - Rendimento médio mensal líquido da população empregada por Profissão, em 2010. Accessed from http://​www.​ine.​pt [last accessed in June 2013] (2010)
  33.Briggs, A.H., O’Brien, B.J., Blackhouse, G.: Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 23, 377–401 (2002)PubMed CrossRef
  34.Briggs, A.H., Wonderling, D.E., Mooney, C.Z.: Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 6(4), 327–340 (1997)PubMed CrossRef
  35.R Foundation for Statistical Computing R: a language and environment for statistical computing [program]. 3.0.1 version. In (2013)
  36.INE: Instituto Nacional de Estatística. Statistics Portugal. Accessed from http://​www.​ine.​pt [last accessed in June 2013]. (2010)
  37.Barber, J., Thompson, S.: Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 9(4), 197–204 (2004). doi:10.​1258/​1355819042250249​ PubMed CrossRef
  38.Basu, A., Manning, W.G.: Issues for the next generation of health care cost analyses. Med. Care 47(7 Suppl 1), S109–S114 (2009). doi:10.​1097/​MLR.​0b013e31819c94a1​ PubMed CrossRef
  39.Dodd, S., Bassi, A., Bodger, K., Williamson, P.: A comparison of multivariable regression models to analyse cost data. J Eval Clin Pract 12(1), 76–86 (2006). doi:10.​1111/​j.​1365-2753.​2006.​00610.​x PubMed CrossRef
  40.Tweedie, MCK.: An index which distinguishes between some important exponential families. In: Ghosh, JKRJ., (ed.) Statistics: applications and new directions. In: Proceedings of the Indian Statistical Institute Golden Jubilee International Conference, Calcutta: Indian Statistical Institute (1984) pp. 579–604
  41.von Lengerke, T., John, J., Mielck, A.: Excess direct medical costs of severe obesity by socioeconomic status in German adults. Psychosoc Med 7, (2010). doi:10.​3205/​psm000063
  42.Buntin, M.B., Zaslavsky, A.M.: Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ 23(3), 525–542 (2004). doi:10.​1016/​j.​jhealeco.​2003.​10.​005 PubMed CrossRef
  43.Burgoyne, D.S.: Prevalence and economic implications of chronic pain. Manag Care 16(2 Suppl 3), 2–4 (2007)PubMed
  44.Gatchel, R.J., Okifuji, A.: Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic nonmalignant pain. J Pain 7(11), 779–793 (2006). doi:10.​1016/​j.​jpain.​2006.​08.​005 PubMed CrossRef
  45.IOM (Institute of Medicine): Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. The National Academies Press, Washington (2011)
  46.Fishman, P., Von Korff, M., Lozano, P., Hecht, J.: Chronic care costs in managed care. Health Aff (Millwood) 16(3), 239–247 (1997)CrossRef
  47.Wenig, C.M., Schmidt, C.O., Kohlmann, T., Schweikert, B.: Costs of back pain in Germany. Eur. J. Pain 13(3), 280–286 (2009). doi:10.​1016/​j.​ejpain.​2008.​04.​005 PubMed CrossRef
  48.Bolten, W., Kempel-Waibel, A., Pforringer, W.: Analysis of the cost of illness in backache. Med Klin (Munich) 93(6), 388–393 (1998)CrossRef
  49.Sculpher, M.J., Pang, F.S., Manca, A., Drummond, M.F., Golder, S., Urdahl, H., Davies, L.M., Eastwood, A.: Generalisability in economic evaluation studies in healthcare: a review and case studies. Health technology assessment 8(49), 1–192 (2004)
  50.Zhao, F.L., Xie, F., Hu, H., Li, S.C.: Transferability of indirect cost of chronic disease: a systematic review and meta-analysis. Pharmacoeconomics 31(6), 501–508 (2013). doi:10.​1007/​s40273-013-0053-6 PubMed CrossRef
  51.Andrew, R., Derry, S., Taylor, R.S., Straube, S., Phillips, C.J.: The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Pract 14(1), 79–94 (2014). doi:10.​1111/​papr.​12050 PubMed CrossRef
  
• 作者单位：Luís Filipe Azevedo (1) (2) (3)
  Altamiro Costa-Pereira (1) (2) (3)
  Liliane Mendonça (3)
  Cláudia Camila Dias (1) (2)
  José M. Castro-Lopes (3) (4) (5)
  
  1. Department of Health Information and Decision Sciences (CIDES), Faculty of Medicine, University of Porto, Rua Dr. Plácido da Costa, s/n, 4200-319, Porto, Portugal
  2. Centre for Research in Health Technologies and Information Systems (CINTESIS), University of Porto, Porto, Portugal
  3. Centro Nacional de Observação em Dor (OBSERVDOR, Portuguese National Pain Observatory), Porto, Portugal
  4. Department of Experimental Biology, Faculty of Medicine, University of Porto, Porto, Portugal
  5. Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal
  
• 刊物类别：Business and Economics
• 刊物主题：Economics
  Economic Policy
  Public Health
  Public Finance and Economics
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1618-7601

文摘

In addition to its high frequency and relevant individual and social impact, chronic pain (CP) has been shown to be a major contributor to increased healthcare utilisation, reduced labour productivity, and consequently large direct and indirect costs. In the context of a larger nationwide study, we aimed to assess the total annual direct and indirect costs associated with CP in Portugal. A population-based study was conducted in a representative sample of the Portuguese adult population. The 5,094 participants were selected using random digit dialling and contacted by computer-assisted telephone interviews. Questionnaires included the brief pain inventory and pain disability index. Estimates were adequately weighted for the population. From all CP subjects identified, a subsample (n = 562) accepted to participate in this economic study. Mean total annualised costs per CP subject of €1,883.30 were observed, amounting to €4,611.69 million nationally, with 42.7 % direct and 57.3 % indirect costs, and corresponding to 2.71 % of the Portuguese annual GDP in 2010. Only socio-demographic variables were significantly and independently associated with CP costs, and not CP severity, raising the possibility of existing inequalities in the distribution of healthcare in Portugal. The high economic impact of CP in Portugal was comprehensively demonstrated. Given the high indirect costs observed, restricting healthcare services is not a rational response to these high societal costs; instead improving the quality of CP prevention and management is recommended. Keywords Chronic pain Costs Productivity Cost of illness Economic impact